captopril has been researched along with Diabetes Mellitus in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (33.33) | 18.7374 |
| 1990's | 10 (30.30) | 18.2507 |
| 2000's | 7 (21.21) | 29.6817 |
| 2010's | 3 (9.09) | 24.3611 |
| 2020's | 2 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Abdillah, R; Almahdy, A; Aquista, PG; Armenia, A; Putri, DP; Wahyuni, FS; Zikra, M | 1 |
| Bakhle, YS | 1 |
| Agabiti-Rosei, E; Manolis, A; Omboni, S; Zava, D | 1 |
| Bae, UJ; Cha, SA; Gao, S; Kim, SH; Park, BH; Park, BM; Park, WH | 1 |
| Agabiti-Rosei, E; Borghi, C; Malacco, E; Manolis, A; Modesti, PA; Napoli, C; Omboni, S; Parati, G | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Esposti, DD | 1 |
| Aguilar, D; Belenkov, YN; Califf, RM; Diaz, R; Francis, GS; Henis, M; Køber, L; Leimberger, JD; McMurray, JJ; O'Connor, CM; Pfeffer, MA; Rouleau, JL; Skali, H; Solomon, SD; Varshavsky, S; Velazquez, EJ | 1 |
| Higashiura, K; Shimamoto, K; Yoshida, D | 1 |
| Al-Shabanah, O; Mariee, AD | 1 |
| Bános, C; Csabuda, M; Gercsák, G; Molnár, Z; Pató, E; Radó, JP | 1 |
| Silberbusch, J; van der Voort, PH; Veenstra, J; Verdegaal, WP; Wildenborg, IH | 1 |
| Yamaguchi, M | 1 |
| Cicco, G; Pirrelli, A | 1 |
| Himmel, W; Kochen, MM; Lönker, B | 1 |
| Barkai, L; Soós, A; Vámosi, I | 1 |
| Arabidze, GG; Filatova, EV; Kukharchuk, VV; Rogoza, AN; Vikhert, OA | 1 |
| Kumar, PD; Rajaratnam, K | 1 |
| Scheen, AJ | 2 |
| Atkinson, AB; Bell, PM; Wiggam, MI | 1 |
| Coca, A; Ruilope, LM | 1 |
| Levinson, PD | 1 |
| Studney, D | 1 |
| Leblanc, H; Marre, M; Passa, P | 1 |
| Fraser, DM; McMurray, J | 1 |
| Barbera, R; Fontana, S; Giachetti, F; Lanza, G | 1 |
| Alberti, KG; Mbanya, JC; Taylor, R; Thomas, TH; Wilkinson, R | 1 |
| Farsang, C | 1 |
| Jovanović, D | 1 |
| Chimori, K; Kosaka, J; Miura, K; Miyazaki, S; Sakanaka, A; Yasuda, K | 1 |
| Graham, P; Naidoo, D | 1 |
| Bringer, J; Ferriere, M; Lachkar, H; Mirouze, J; Orsetti, A; Richard, JL | 1 |
| Elling, H; Elling, P | 1 |
9 review(s) available for captopril and Diabetes Mellitus
| Article | Year |
|---|---|
How ACE inhibitors transformed the renin-angiotensin system.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus; Humans; Hypertension; Renin-Angiotensin System | 2020 |
Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Biphenyl Compounds; Blood Glucose; Blood Pressure; C-Reactive Protein; Captopril; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Inflammation Mediators; Irbesartan; Lipids; Male; Middle Aged; Pulse Wave Analysis; Randomized Controlled Trials as Topic; Risk Factors; Tetrazoles; Vascular Stiffness | 2017 |
[Treatment of hypertensive patients with impaired glucose tolerance (IGT)].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Glucose Intolerance; Humans; Hypertension; Insulin Resistance; Life Style; Losartan; Nifedipine; Risk | 2005 |
[The effect of captopril therapy on the degree of microalbuminuria in diabetic children and adolescents with incipient nephropathy].
Topics: Adolescent; Albuminuria; Captopril; Child; Diabetes Mellitus; Diabetic Nephropathies; Female; Humans; Male; Treatment Outcome | 1996 |
Renal diseases in diabetes mellitus.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Calcium Channel Blockers; Captopril; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Peritoneal Dialysis, Continuous Ambulatory; Prognosis; Urinary Tract Infections | 1997 |
[Renin-angiotensin system blockade reduces cardiovascular mortality and morbidity attributable to arterial hypertension by primary and secondary prevention. The end of the road?].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension; Kidney Diseases; Primary Prevention; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Time Factors | 2000 |
Beta-blockers, diabetes, and hypoglycemia: risky business?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Randomized Controlled Trials as Topic; Risk Factors; Time Factors | 2001 |
Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications.
Topics: Albuminuria; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Irbesartan; Kidney Diseases; Losartan; Prognosis; Ramipril; Tetrazoles | 2002 |
Important clinicopharmacological aspects of captopril.
Topics: Asthma; Biomechanical Phenomena; Captopril; Child; Diabetes Mellitus; Drug Interactions; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renovascular; Pediatrics; Poisoning | 1988 |
3 trial(s) available for captopril and Diabetes Mellitus
| Article | Year |
|---|---|
Zofenopril plus hydrochlorothiazide and irbesartan plus hydrochlorothiazide in previously treated and uncontrolled diabetic and non-diabetic essential hypertensive patients.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Biphenyl Compounds; Captopril; Case-Control Studies; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Middle Aged; Tetrazoles; Treatment Outcome; Young Adult | 2014 |
Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatine Kinase; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Smoking; Survival Analysis; Time Factors | 2003 |
[Clinical study of the month. The CAPPP study: "The Captopril Prevention Project"].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Cerebrovascular Disorders; Diabetes Mellitus; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Treatment Outcome | 1999 |
21 other study(ies) available for captopril and Diabetes Mellitus
| Article | Year |
|---|---|
Blood pressure and blood sugar-lowering effects of purified gambir on diabetic hypertensive Wistar Kyoto rats.
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Blood Pressure; Captopril; Catechin; Diabetes Mellitus; Glyburide; Hypertension; Hypoglycemic Agents; Plant Extracts; Prednisone; Rats; Rats, Inbred WKY; Sodium Chloride | 2022 |
Oxidative stress increases the risk of pancreatic β cell damage in chronic renal hypertensive rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Deoxyguanosine; Diabetes Mellitus; Hypertension; Insulin; Insulin Secretion; Insulin-Secreting Cells; Kidney; Male; Models, Animal; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Pancreas; Rats; Rats, Sprague-Dawley; Thioctic Acid | 2016 |
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cohort Studies; Comorbidity; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Life Tables; Male; Medical Records; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk; Stroke; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
Protective ability and binding affinity of captopril towards serum albumin in an in vitro glycation model of diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus; Glycated Serum Albumin; Glycation End Products, Advanced; Glycosylation; Hypertension; In Vitro Techniques; Protein Binding; Protein Conformation; Serum Albumin; Spectrometry, Fluorescence | 2006 |
Glucose-induced hyperkalemia developing in the upright position in captopril-treated hypertensives.
Topics: Adolescent; Adult; Aged; Aldosterone; Captopril; Diabetes Mellitus; Female; Glucose; Glucose Tolerance Test; Humans; Hyperkalemia; Hypertension; Male; Middle Aged; Posture; Proline | 1982 |
ACE inhibitors and hypoglycaemia.
Topics: Absorption; Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus; Humans; Hypoglycemia; Injections, Subcutaneous; Insulin | 1995 |
[A study on the pathogenesis of hyporeninemia in diabetics].
Topics: Adult; Aged; Blood Pressure; Captopril; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Enzyme Precursors; Female; Humans; Hypoaldosteronism; Male; Middle Aged; Renin; Sodium, Dietary | 1994 |
[Glyco-lipid changes in hypertensive diabetic patients undergoing treatment with nifedipine and captopril].
Topics: Adult; Blood Glucose; Captopril; Cholesterol; Diabetes Complications; Diabetes Mellitus; Follow-Up Studies; Humans; Hypertension; Middle Aged; Nifedipine; Triglycerides | 1993 |
[Relevance of general practitioner's prescriptions for hospital pharmacotherapy. A survey of hospital physicians].
Topics: Aged; Attitude of Health Personnel; Captopril; Data Interpretation, Statistical; Diabetes Mellitus; Drug Combinations; Drug Prescriptions; Drug Therapy; Family Practice; Female; Flavonoids; Ginkgo biloba; Hemostatics; Humans; Hydrochlorothiazide; Hypertension; Male; Medical Staff, Hospital; Middle Aged; Plant Extracts; Prostatic Hyperplasia; Sitosterols; Surveys and Questionnaires | 1996 |
[A comparison of the effect of Capoten (captopril) and ramipril on the circadian profile of the arterial pressure and peripheral hemodynamics in patients with hypertension combined with diabetes mellitus].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus; Drug Evaluation; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Myocardial Ischemia; Ramipril | 1996 |
CAPPP trial. Captopril Prevention Project.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cerebrovascular Disorders; Diabetes Complications; Diabetes Mellitus; Humans; Hypertension; Middle Aged | 1999 |
CAPPP trial. Captopril Prevention Project.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus; Diuretics; Humans; Hypertension | 1999 |
[Treatment of arterial hypertension in diabetics. Contribution of converting enzyme inhibitors].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diuretics; Enalapril; Humans; Hypertension; Obesity; Vasodilator Agents | 1985 |
Captopril, enalapril, and blood glucose.
Topics: Blood Glucose; Captopril; Diabetes Mellitus; Enalapril; Humans; Hypertension | 1986 |
[Long-term treatment of hypertension in the diabetic patient with captopril. 8- to 12-month follow-up].
Topics: Adult; Aged; Aged, 80 and over; Captopril; Diabetes Complications; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged | 1987 |
Hypertension and diabetes mellitus: erythrocyte electrolytes and the effect of captopril treatment.
Topics: Biological Transport; Captopril; Diabetes Complications; Diabetes Mellitus; Electrolytes; Erythrocytes; Female; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged | 1988 |
[Captopril in the ambulatory treatment of arterial hypertension in diabetics].
Topics: Adult; Aged; Captopril; Diabetes Complications; Diabetes Mellitus; Female; Humans; Hypertension; Male; Middle Aged | 1987 |
The hypotensive effect of single-dose captopril in diabetics.
Topics: Blood Pressure; Captopril; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Drug Evaluation; Gabexate; Guanidines; Humans; Hypertension; Kallikreins; Renin | 1986 |
False-positive ketostix in a diabetic on antihypertensive therapy.
Topics: Captopril; Diabetes Mellitus; False Positive Reactions; Female; Humans; Ketones; Reagent Strips | 1987 |
Captopril and insulin sensitivity.
Topics: Blood Glucose; Captopril; Diabetes Mellitus; Drug Interactions; Humans; Insulin; Proline | 1985 |
Penicillamine, captopril, and hypoglycemia.
Topics: Adult; Captopril; Diabetes Mellitus; Female; Humans; Hypoglycemia; Male; Middle Aged; Penicillamine; Proline | 1985 |